These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 27586843

  • 1. Selective Modulator of Cannabinoid Receptor Type 2 Reduces Memory Impairment and Infarct Size During Cerebral Hypoperfusion and Vascular Dementia.
    Jayant S, Sharma B.
    Curr Neurovasc Res; 2016; 13(4):289-302. PubMed ID: 27586843
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological modulation of I(1)-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia.
    Gupta S, Sharma B.
    Eur J Pharmacol; 2014 Jan 15; 723():80-90. PubMed ID: 24333661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia.
    Gupta S, Singh P, Sharma BM, Sharma B.
    Curr Neurovasc Res; 2015 Jan 15; 12(3):240-52. PubMed ID: 26036976
    [Abstract] [Full Text] [Related]

  • 8. Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition.
    Singh P, Gupta S, Sharma B.
    Curr Neurovasc Res; 2016 Jan 15; 13(3):219-29. PubMed ID: 27189349
    [Abstract] [Full Text] [Related]

  • 9. Oral administration of grape seed polyphenol extract restores memory deficits in chronic cerebral hypoperfusion rats.
    Chen C, Zheng Y, Wu T, Wu C, Cheng X.
    Behav Pharmacol; 2017 Apr 15; 28(2 and 3-Spec Issue):207-213. PubMed ID: 27984208
    [Abstract] [Full Text] [Related]

  • 10. Melatonin receptor and KATP channel modulation in experimental vascular dementia.
    Singh P, Gupta S, Sharma B.
    Physiol Behav; 2015 Apr 01; 142():66-78. PubMed ID: 25659733
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chronic cerebral hypoperfusion-induced memory impairment and hippocampal long-term potentiation deficits are improved by cholinergic stimulation in rats.
    Damodaran T, Müller CP, Hassan Z.
    Pharmacol Rep; 2019 Jun 01; 71(3):443-448. PubMed ID: 31003155
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cinepazide Maleate Improves Cognitive Function and Protects Hippocampal Neurons in Diabetic Rats with Chronic Cerebral Hypoperfusion.
    Li Y, Zhang T, Zhang X, Zou W, Gong X, Fu J.
    Biol Pharm Bull; 2017 Mar 01; 40(3):249-255. PubMed ID: 27990002
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Melatonin improves cognitive function by suppressing endoplasmic reticulum stress and promoting synaptic plasticity during chronic cerebral hypoperfusion in rats.
    Thangwong P, Jearjaroen P, Govitrapong P, Tocharus C, Tocharus J.
    Biochem Pharmacol; 2022 Apr 01; 198():114980. PubMed ID: 35219702
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The potential protective effects of cannabinoid receptor agonist WIN55,212-2 on cognitive dysfunction is associated with the suppression of autophagy and inflammation in an experimental model of vascular dementia.
    Wang DP, Yin H, Kang K, Lin Q, Su SH, Hai J.
    Psychiatry Res; 2018 Sep 01; 267():281-288. PubMed ID: 29945070
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.